| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.3B | $23.0B | $21.7B | $19.1B | $36.3B | $33.0B | $8.3B | $8.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.1B | $4.3B | $4.0B | $3.3B | $2.7B | $2.8B | $1.0B | $0.7B |
| Net Income | $2.8B | $2.5B | $2.3B | $2.2B | $1.8B | $2.0B | $3.0B | $2.1B |
| EPS (Basic) | — | — | — | — | $1.74 | $2.01 | $0.79 | $0.16 |
| EPS (Diluted) | — | — | — | — | $1.74 | $2.01 | $0.79 | $0.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $116.6B | $107.8B | $101.5B | $95.3B | $133.0B | $129.3B | $125.0B | $119.7B |
| Current Assets | $9.5B | $8.4B | $7.8B | $7.3B | $14.0B | $12.6B | $12.0B | $13.4B |
| Cash & Equivalents | $0.6B | $0.4B | $0.4B | $0.4B | $1.2B | $0.7B | $0.6B | $1.3B |
| Total Liabilities | $87.8B | $80.9B | $75.8B | $70.6B | $98.2B | $94.4B | $90.4B | $86.6B |
| Current Liabilities | $10.3B | $9.6B | $9.6B | $10.6B | $16.1B | $12.8B | $14.2B | $11.4B |
| Stockholders' Equity | $28.8B | $26.9B | $25.8B | $24.7B | $34.4B | $32.6B | $32.2B | $30.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.3B | $5.6B | $4.7B | $4.9B | $3.0B | $4.2B | $6.7B | $8.6B |
| Investing Cash Flow | $-8.5B | $-7.0B | $-7.4B | $-7.0B | $-3.3B | $-4.3B | $-7.3B | $-7.8B |
| Capital Expenditures | $8.5B | $7.1B | $7.4B | $7.1B | $8.0B | $8.0B | $7.2B | $7.6B |
| Financing Cash Flow | $2.5B | $1.3B | $2.7B | $1.6B | $0.8B | $0.1B | $-0.1B | $-0.2B |